Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson’s Disease by Diego Santos-García, Lydia López-Manzanares, Inés Muro, Pablo Lorenzo-Barreto, Elena Casas Peña, Rocío García-Ramos, Tamara Fernández Valle, Carlos Morata-Martínez, Raquel Baviera-Muñoz, Irene Martínez-Torres, María Álvarez-Sauco, Déborah Alonso-Modino, Inés Legarda, María Fuensanta Valero-García, José Andrés Suárez-Muñoz, Juan Carlos Martínez-Castrillo, Ana Belén Perona, Jose María Salom, Esther Cubo, Caridad Valero-Merino, Nuria López-Ariztegui, Pilar Sánchez Alonso, Sabela Novo Ponte, Elisa Gamo Gónzález, Raquel Martín García, Raúl Espinosa, Mar Carmona, Cici Esmerali Feliz, Pedro García Ruíz, Teresa Muñoz Ruíz, Beatriz Fernández Rodríguez, Marina Mata Alvarez-Santullano

Get full text